Olakunle James Onaolapo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Olakunle James Onaolapo has a total of 142 co-authors. Here are the top co-authors by number of shared publications:
- Adejoke Yetunde Onaolapo
Behavioural Neuroscience and Neurobiology Unit, Department of Anatomy, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
86 shared publications - Anthony Tope Olofinnade
Department of Pharmacology, Therapeutics and Toxicology, Faculty of Basic Clinical Sciences, College of Medicine, Lagos State University, Ikeja, Lagos State, Nigeria
14 shared publications Adejoke Yetunde Onaolapo
Behavioural Neuroscience Unit, Neurobiology Subdivision, Department of Anatomy, Ladoke Akintola University of Technology, Oyo State 234, Nigeria
6 shared publicationsAdejoke Y. Onaolapo
Behavioural Neuroscience Unit, Neurobiology Subdivision Department of Anatomy, Ladoke Akintola University of Technology, Ogbomosho, Oyo State,Nigeria
4 shared publicationsAkinsanmi Akinsehinwa
Federal University Oye-Ekiti
4 shared publicationsBoluwatife Mary Oladipupo
Ladoke Akintola University of Technology
4 shared publications
Latest Publications
- 6 October 2026
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 25, 1-14
Protective Effects of Phenytoin and Spironolactone against 5-Fluorouracil-induced Alopecia: Involvement of Antioxidant, Anti-inflammatory, and Collagen-regenerative Mechanisms
Introduction: Chemotherapy-induced alopecia (CIA) is one of the most distressing adverse effects of cancer treatment and is primarily associated with oxidative stress, inflammation, and damage to hair follicles. Effective preventive and therapeutic options remain limited. This study evaluated the protective effects of oral phenytoin and spironolactone against 5-fluorouracil (5-FU)- induced alopecia in rats. Methods: CIA was induced in rats using intraperitoneal administration of 5-FU, followed by daily oral treatment with phenytoin or spironolactone for 21 days. Feed intake, body weight, and hair regrowth were monitored throughout the study. Blood and skin samples were collected for assessment of oxidative stress markers, inflammatory cytokines, and histological changes using Haematoxylin and Eosin and Von Gieson staining. results: Following 5-FU administration, rats exhibited significant reductions in feed intake and body weight, accompanied by visible alopecia, incomplete hair regrowth, and follicular dystrophy; consistent with chemotherapy-induced systemic and dermal toxicity. Treatment with phenytoin or spironolactone markedly reversed 5-FU–induced weight loss, restored appetite, and improved overall activity, suggesting recovery of metabolic and physiological functions. Both agents significantly attenuated oxidative stress, as evidenced by reduced plasma malondialdehyde (MDA) levels, and modulated inflammatory responses by decreasing TNF-α and IL-1β while restoring IL-10 levels. Histological analysis revealed that 5-FU caused dermal papilla distortion, follicular shrinkage, and loss of anagen follicles; while phenytoin and spironolactone restored follicular morphology, hair shaft integrity, and anagen activity. Results: 5-FU administration significantly reduced feed intake and body weight and induced marked alopecia, impaired hair regrowth, and follicular degeneration. Treatment with phenytoin and spironolactone improved appetite, attenuated weight loss, and enhanced hair regrowth. Both agents significantly reduced oxidative stress, as evidenced by decreased plasma malondialdehyde (MDA) levels, lowered TNF-α and IL-1β concentrations, and restored IL-10 levels. Histological analyses revealed that 5-FU caused dermal papilla distortion, follicular shrinkage, loss of anagen follicles, and disruption of collagen organization. These alterations were markedly ameliorated by both treatments, with improved follicular architecture, hair shaft integrity, collagen organization, and anagen activity. Phenytoin produced greater improvements in selected hair morphometric indices. Discussion: The findings indicate that attenuation of oxidative stress and inflammation was accompanied by improved follicular structure and hair regrowth, suggesting that these mechanisms may contribute to the protective effects of both agents. The greater improvement in selected morphometric indices with phenytoin indicates potentially differential effects on follicular recovery. Conclusion: Phenytoin and spironolactone effectively attenuated 5-FU-induced alopecia, oxidative stress, inflammation, and follicular damage. Their protective effects suggest potential therapeutic utility in promoting post-chemotherapy hair recovery and improving treatment outcomes.
- 6 October 2026
- Published by Bentham Science Publishers Ltd. in Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
- Vol. 25, 1-14
Protective Effects of Phenytoin and Spironolactone against 5-Fluorouracil-induced Alopecia: Involvement of Antioxidant, Anti-inflammatory, and Collagen-regenerative Mechanisms
Introduction: Chemotherapy-induced alopecia (CIA) is one of the most distressing adverse effects of cancer treatment and is primarily associated with oxidative stress, inflammation, and damage to hair follicles. Effective preventive and therapeutic options remain limited. This study evaluated the protective effects of oral phenytoin and spironolactone against 5-fluorouracil (5-FU)- induced alopecia in rats. Methods: CIA was induced in rats using intraperitoneal administration of 5-FU, followed by daily oral treatment with phenytoin or spironolactone for 21 days. Feed intake, body weight, and hair regrowth were monitored throughout the study. Blood and skin samples were collected for assessment of oxidative stress markers, inflammatory cytokines, and histological changes using Haematoxylin and Eosin and Von Gieson staining. results: Following 5-FU administration, rats exhibited significant reductions in feed intake and body weight, accompanied by visible alopecia, incomplete hair regrowth, and follicular dystrophy; consistent with chemotherapy-induced systemic and dermal toxicity. Treatment with phenytoin or spironolactone markedly reversed 5-FU–induced weight loss, restored appetite, and improved overall activity, suggesting recovery of metabolic and physiological functions. Both agents significantly attenuated oxidative stress, as evidenced by reduced plasma malondialdehyde (MDA) levels, and modulated inflammatory responses by decreasing TNF-α and IL-1β while restoring IL-10 levels. Histological analysis revealed that 5-FU caused dermal papilla distortion, follicular shrinkage, and loss of anagen follicles; while phenytoin and spironolactone restored follicular morphology, hair shaft integrity, and anagen activity. Results: 5-FU administration significantly reduced feed intake and body weight and induced marked alopecia, impaired hair regrowth, and follicular degeneration. Treatment with phenytoin and spironolactone improved appetite, attenuated weight loss, and enhanced hair regrowth. Both agents significantly reduced oxidative stress, as evidenced by decreased plasma malondialdehyde (MDA) levels, lowered TNF-α and IL-1β concentrations, and restored IL-10 levels. Histological analyses revealed that 5-FU caused dermal papilla distortion, follicular shrinkage, loss of anagen follicles, and disruption of collagen organization. These alterations were markedly ameliorated by both treatments, with improved follicular architecture, hair shaft integrity, collagen organization, and anagen activity. Phenytoin produced greater improvements in selected hair morphometric indices. Discussion: The findings indicate that attenuation of oxidative stress and inflammation was accompanied by improved follicular structure and hair regrowth, suggesting that these mechanisms may contribute to the protective effects of both agents. The greater improvement in selected morphometric indices with phenytoin indicates potentially differential effects on follicular recovery. Conclusion: Phenytoin and spironolactone effectively attenuated 5-FU-induced alopecia, oxidative stress, inflammation, and follicular damage. Their protective effects suggest potential therapeutic utility in promoting post-chemotherapy hair recovery and improving treatment outcomes.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH in Acta Bioscientia: Journal of Biomedical and Biological Science Research
- Vol. 2 (5) , 657-666
Kalanchoe pinnata Attenuates Cyclophosphamide-Induced Testicular and Sperm Alterations in Wistar Rats: Histomorphological and Endocrine Evidence
This study investigated the protective potential of ethanolic Kalanchoe pinnata (KP) leaf extract against cyclophosphamide (CYP)-induced reproductive toxicity in male Wistar rats. Eighty male Wistar rats (120–160 g) were randomly assigned to eight groups (n = 10/group): control; KP alone (200, 400, and 600 mg/kg/day, orally, for 14 days); CYP alone (50 mg/kg, intraperitoneally, on Day 1); and CYP + KP groups receiving the Day 1 CYP injection followed by daily oral KP administration for 14 days. Sperm characteristics, serum FSH, LH, testosterone and oestradiol, MDA, TAC, TNF-α and IL-1β, behavioural performance, and quantitative testicular histomorphometry were assessed CYP significantly reduced total sperm count, rapid progressive motility, and normal sperm morphology while increasing dead sperm cells. CYP exposure was also associated with reduced testosterone, increased FSH and LH, elevated MDA, reduced TAC, and impaired working-memory performance. Co-treatment with KP attenuated several CYP-associated reproductive alterations. The 400 mg/kg dose produced the greatest improvement in testosterone and TAC, with values of 20.02 ± 7.30 ng/mL and 13.7 ± 1.6, respectively, whereas 600 mg/kg produced the greatest reduction in MDA (0.94 ± 0.04 μmol/L). Quantitative histomorphometry further indicated preservation of seminiferous tubular architecture and germinal epithelial thickness following KP co-treatment. Ethanolic K. pinnata leaf extract attenuated several CYP-associated alterations in sperm characteristics, reproductive endocrine measures, oxidative status, behaviour, and testicular histomorphology. These findings support further investigation of KP as a potential protective intervention against cyclophosphamide-associated reproductive injury.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH in Acta Bioscientia: Journal of Biomedical and Biological Science Research
- Vol. 2 (5) , 657-666
Open AccessKalanchoe pinnata Attenuates Cyclophosphamide-Induced Testicular and Sperm Alterations in Wistar Rats: Histomorphological and Endocrine Evidence
This study investigated the protective potential of ethanolic Kalanchoe pinnata (KP) leaf extract against cyclophosphamide (CYP)-induced reproductive toxicity in male Wistar rats. Eighty male Wistar rats (120–160 g) were randomly assigned to eight groups (n = 10/group): control; KP alone (200, 400, and 600 mg/kg/day, orally, for 14 days); CYP alone (50 mg/kg, intraperitoneally, on Day 1); and CYP + KP groups receiving the Day 1 CYP injection followed by daily oral KP administration for 14 days. Sperm characteristics, serum FSH, LH, testosterone and oestradiol, MDA, TAC, TNF-α and IL-1β, behavioural performance, and quantitative testicular histomorphometry were assessed CYP significantly reduced total sperm count, rapid progressive motility, and normal sperm morphology while increasing dead sperm cells. CYP exposure was also associated with reduced testosterone, increased FSH and LH, elevated MDA, reduced TAC, and impaired working-memory performance. Co-treatment with KP attenuated several CYP-associated reproductive alterations. The 400 mg/kg dose produced the greatest improvement in testosterone and TAC, with values of 20.02 ± 7.30 ng/mL and 13.7 ± 1.6, respectively, whereas 600 mg/kg produced the greatest reduction in MDA (0.94 ± 0.04 μmol/L). Quantitative histomorphometry further indicated preservation of seminiferous tubular architecture and germinal epithelial thickness following KP co-treatment. Ethanolic K. pinnata leaf extract attenuated several CYP-associated alterations in sperm characteristics, reproductive endocrine measures, oxidative status, behaviour, and testicular histomorphology. These findings support further investigation of KP as a potential protective intervention against cyclophosphamide-associated reproductive injury.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 632-644
Behavioural, Neurochemical, and Brain Histomorphological Effects of Repeated Propofol Administration in Wistar Rats
Propofol is a widely used intravenous anaesthetic whose principal central nervous system action involves potentiation of γ-aminobutyric acid type A (GABA_A) receptor-mediated inhibitory neurotransmission. Although propofol has recognised neuroprotective, antioxidant, and anti-inflammatory properties, repeated or prolonged exposure may produce dose- and context-dependent neural alterations. This study investigated the behavioural, circulating neurochemical, biochemical, and brain histomorphological effects of repeated propofol administration in Wistar rats. Forty Wistar rats, comprising 20 males and 20 females, were allocated to four groups (n = 10; 5 males and 5 females per group): control, 0.5, 1.0, and 1.5 mg/kg propofol groups. Behavioural assessments included the open-field test, elevated plus maze, and Y-maze, while body weight and feed intake were monitored. Serum dopamine, acetylcholine, serotonin, malondialdehyde (MDA), total antioxidant capacity (TAC), tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) were determined. The dentate gyrus and prefrontal cortex were examined histologically. Data were analysed using one-way analysis of variance followed by Tukey’s multiple-comparison test. Repeated propofol exposure significantly altered feed intake, line crossing, rearing, elevated-plus-maze behaviour, and Y-maze performance, whereas body weight and self-grooming were not significantly altered. Serum dopamine decreased progressively, whereas acetylcholine increased at the medium and high doses. MDA increased significantly, accompanied by increased TAC at the highest dose. TNF-α and IL-10 were significantly reduced, whereas IL-1β was unchanged. Histological examination demonstrated dose-related neuronal distortion and degenerative changes in the dentate gyrus and prefrontal cortex. Repeated propofol administration was associated with behavioural, circulating neurochemical, biochemical, and brain histomorphological alterations following repeated propofol exposure.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 632-644
Open AccessBehavioural, Neurochemical, and Brain Histomorphological Effects of Repeated Propofol Administration in Wistar Rats
Propofol is a widely used intravenous anaesthetic whose principal central nervous system action involves potentiation of γ-aminobutyric acid type A (GABA_A) receptor-mediated inhibitory neurotransmission. Although propofol has recognised neuroprotective, antioxidant, and anti-inflammatory properties, repeated or prolonged exposure may produce dose- and context-dependent neural alterations. This study investigated the behavioural, circulating neurochemical, biochemical, and brain histomorphological effects of repeated propofol administration in Wistar rats. Forty Wistar rats, comprising 20 males and 20 females, were allocated to four groups (n = 10; 5 males and 5 females per group): control, 0.5, 1.0, and 1.5 mg/kg propofol groups. Behavioural assessments included the open-field test, elevated plus maze, and Y-maze, while body weight and feed intake were monitored. Serum dopamine, acetylcholine, serotonin, malondialdehyde (MDA), total antioxidant capacity (TAC), tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-10 (IL-10) were determined. The dentate gyrus and prefrontal cortex were examined histologically. Data were analysed using one-way analysis of variance followed by Tukey’s multiple-comparison test. Repeated propofol exposure significantly altered feed intake, line crossing, rearing, elevated-plus-maze behaviour, and Y-maze performance, whereas body weight and self-grooming were not significantly altered. Serum dopamine decreased progressively, whereas acetylcholine increased at the medium and high doses. MDA increased significantly, accompanied by increased TAC at the highest dose. TNF-α and IL-10 were significantly reduced, whereas IL-1β was unchanged. Histological examination demonstrated dose-related neuronal distortion and degenerative changes in the dentate gyrus and prefrontal cortex. Repeated propofol administration was associated with behavioural, circulating neurochemical, biochemical, and brain histomorphological alterations following repeated propofol exposure.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 618-631
Comparative Effects of Artesunate, Clindamycin and Their Combination on Parasitaemia, Body Weight and Open-Field Behaviour in Plasmodium berghei ANKA-Infected Wistar Rats
Malaria treatment studies often infer efficacy from parasite clearance, although functional responses may follow different trajectories. This study compared artesunate, clindamycin and their combination in Plasmodium berghei ANKA-infected Wistar rats. Sixty-four rats were allocated equally to eight infected or uninfected groups receiving vehicle, artesunate (4 mg/kg/day intraperitoneally), clindamycin (10 mg/kg/day orally), or both drugs on Days 3–7 post-inoculation. Day 3 assessments preceded the first dose. Parasitaemia was monitored on Days 3–8 in infected rats; body weight and open-field line crossing, rearing and grooming were also evaluated. Parasitaemia showed a significant time-by-treatment interaction (Greenhouse–Geisser F (9.643, 89.998) = 366.461, p < 0.001, partial η² = 0.975). Artesunate produced microscopically undetectable parasitaemia by Day 6, whereas clindamycin and the combination did so by Day 7. Mean Day 3–8 parasitaemia area under the curve was 45.65 ± 1.16 %-days with infected vehicle, 8.01 ± 0.22 with artesunate, 9.27 ± 0.46 with clindamycin and 7.44 ± 0.31 with combination therapy (Welch F (3, 14.442) = 2547.698, p < 0.001); every pairwise comparison was significant. Time-by-group interactions were significant for line crossing, rearing and grooming, but the combination showed no consistent behavioural advantage. Day 7 body weight differed among groups after adjustment for Day 3 weight (F (7, 55) = 4.703, p < 0.001). All animals reached the scheduled Day 8 endpoint. Artesunate provided the earliest microscopic clearance, while the combination modestly reduced cumulative parasite exposure without demonstrating pharmacological synergy or uniform behavioural benefit.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 618-631
Open AccessComparative Effects of Artesunate, Clindamycin and Their Combination on Parasitaemia, Body Weight and Open-Field Behaviour in Plasmodium berghei ANKA-Infected Wistar Rats
Malaria treatment studies often infer efficacy from parasite clearance, although functional responses may follow different trajectories. This study compared artesunate, clindamycin and their combination in Plasmodium berghei ANKA-infected Wistar rats. Sixty-four rats were allocated equally to eight infected or uninfected groups receiving vehicle, artesunate (4 mg/kg/day intraperitoneally), clindamycin (10 mg/kg/day orally), or both drugs on Days 3–7 post-inoculation. Day 3 assessments preceded the first dose. Parasitaemia was monitored on Days 3–8 in infected rats; body weight and open-field line crossing, rearing and grooming were also evaluated. Parasitaemia showed a significant time-by-treatment interaction (Greenhouse–Geisser F (9.643, 89.998) = 366.461, p < 0.001, partial η² = 0.975). Artesunate produced microscopically undetectable parasitaemia by Day 6, whereas clindamycin and the combination did so by Day 7. Mean Day 3–8 parasitaemia area under the curve was 45.65 ± 1.16 %-days with infected vehicle, 8.01 ± 0.22 with artesunate, 9.27 ± 0.46 with clindamycin and 7.44 ± 0.31 with combination therapy (Welch F (3, 14.442) = 2547.698, p < 0.001); every pairwise comparison was significant. Time-by-group interactions were significant for line crossing, rearing and grooming, but the combination showed no consistent behavioural advantage. Day 7 body weight differed among groups after adjustment for Day 3 weight (F (7, 55) = 4.703, p < 0.001). All animals reached the scheduled Day 8 endpoint. Artesunate provided the earliest microscopic clearance, while the combination modestly reduced cumulative parasite exposure without demonstrating pharmacological synergy or uniform behavioural benefit.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 606-617
Neurobehavioural, Biochemical and Histological Effects of Metformin in a Scopolamine-Induced Cognitive Impairment Model in Male Wistar Rats
Alzheimer’s disease (AD) causes progressive memory loss and cognitive decline. Current treatments, including donepezil, provide mainly symptomatic relief, prompting interest in drug repurposing. Metformin, an antidiabetic drug, has demonstrated promising neuroprotective effects beyond glycaemic control. The present study assessed the effects of metformin on behavioural, systemic biochemical, and histological alterations in a scopolamine-induced cognitive impairment model in male Wistar rats. Fifty rats weighing 200–240 g were randomly assigned to five groups (n=10). Group A received normal saline and distilled water; Group B received scopolamine (1 mg/kg); Group C received scopolamine (1 mg/kg) and donepezil (3 mg/kg); Groups D and E received scopolamine (1 mg/kg) with metformin at 100 and 200 mg/kg, respectively. Scopolamine was administered intraperitoneally for 7 days, while metformin, donepezil, and vehicle treatments were administered orally for 21 days. Behavioural assessments were conducted on day 28. Scopolamine administration was associated with alterations in behavioural performance, systemic biochemical indices, and neuronal morphology. Metformin treatment was associated with improvements in locomotor activity, spatial working memory, and recognition memory. Serum biochemical analyses demonstrated treatment-related alterations in malondialdehyde, total antioxidant capacity, tumour necrosis factor-α, interleukin-1β, interleukin-10, and acetylcholinesterase activity relative to the scopolamine group. Histological examination showed preservation of neuronal architecture in the prefrontal cortex and CA1 region of the hippocampus following metformin treatment. Overall, metformin attenuated selected behavioural, systemic biochemical, and histological alterations associated with scopolamine-induced cognitive impairment. These findings support further investigation of metformin in experimental models of cognitive dysfunction.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 606-617
Open AccessNeurobehavioural, Biochemical and Histological Effects of Metformin in a Scopolamine-Induced Cognitive Impairment Model in Male Wistar Rats
Alzheimer’s disease (AD) causes progressive memory loss and cognitive decline. Current treatments, including donepezil, provide mainly symptomatic relief, prompting interest in drug repurposing. Metformin, an antidiabetic drug, has demonstrated promising neuroprotective effects beyond glycaemic control. The present study assessed the effects of metformin on behavioural, systemic biochemical, and histological alterations in a scopolamine-induced cognitive impairment model in male Wistar rats. Fifty rats weighing 200–240 g were randomly assigned to five groups (n=10). Group A received normal saline and distilled water; Group B received scopolamine (1 mg/kg); Group C received scopolamine (1 mg/kg) and donepezil (3 mg/kg); Groups D and E received scopolamine (1 mg/kg) with metformin at 100 and 200 mg/kg, respectively. Scopolamine was administered intraperitoneally for 7 days, while metformin, donepezil, and vehicle treatments were administered orally for 21 days. Behavioural assessments were conducted on day 28. Scopolamine administration was associated with alterations in behavioural performance, systemic biochemical indices, and neuronal morphology. Metformin treatment was associated with improvements in locomotor activity, spatial working memory, and recognition memory. Serum biochemical analyses demonstrated treatment-related alterations in malondialdehyde, total antioxidant capacity, tumour necrosis factor-α, interleukin-1β, interleukin-10, and acetylcholinesterase activity relative to the scopolamine group. Histological examination showed preservation of neuronal architecture in the prefrontal cortex and CA1 region of the hippocampus following metformin treatment. Overall, metformin attenuated selected behavioural, systemic biochemical, and histological alterations associated with scopolamine-induced cognitive impairment. These findings support further investigation of metformin in experimental models of cognitive dysfunction.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 596-605
Vitamin A Attenuates High-Fat High-Sugar Diet-Associated Intestinal and Hippocampal Alterations in Wistar Rats: Implications for Gut-Brain Axis Dysfunction
High-fat high-sugar diets (HFHSD) are associated with metabolic disturbances, intestinal and hippocampal alterations, inflammation, and oxidative stress, which may contribute to gut-brain axis dysfunction. This study evaluated the effects of vitamin A on metabolic, inflammatory, and oxidative stress parameters and intestinal and hippocampal alterations in Wistar rats exposed to an HFHSD. Sixty Wistar rats (80–120 g) were randomly assigned to six groups (n = 10). Groups A–C received standard chow, whereas Groups D–F received an HFHSD containing 30% vegetable oil and 25% sucrose for 28 days. Vitamin A (500 or 1000 IU/kg/day) was administered orally to Groups B and C, respectively, and co-administered with the HFHSD in Groups E and F. Behavioural and cognitive performance were assessed using the Open Field Test, Y-maze, and Novel Object Recognition test. Blood glucose, adiponectin, leptin, TNF-α, IL-6, IL-10, malondialdehyde (MDA), and total antioxidant capacity (TAC), and hippocampal and ileal histopathology were evaluated. HFHSD increased body weight gain, feed intake, TNF-α, IL-6, and MDA, while blood glucose was numerically higher but not significantly different from controls. Adiponectin, leptin, IL-10, and TAC were reduced, accompanied by impaired locomotor and exploratory activity, cognitive deficits, and intestinal and hippocampal histopathological alterations. Vitamin A attenuated metabolic, inflammatory, oxidative, behavioural, and histopathological alterations. The 500 IU/kg dose showed greater improvement in several behavioural and histological outcomes, whereas 1000 IU/kg produced stronger effects on antioxidant status and glycaemic regulation. These findings indicate dose-specific differences in the effects of vitamin A, although the optimal dose and underlying mechanisms remain to be established.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 596-605
Open AccessVitamin A Attenuates High-Fat High-Sugar Diet-Associated Intestinal and Hippocampal Alterations in Wistar Rats: Implications for Gut-Brain Axis Dysfunction
High-fat high-sugar diets (HFHSD) are associated with metabolic disturbances, intestinal and hippocampal alterations, inflammation, and oxidative stress, which may contribute to gut-brain axis dysfunction. This study evaluated the effects of vitamin A on metabolic, inflammatory, and oxidative stress parameters and intestinal and hippocampal alterations in Wistar rats exposed to an HFHSD. Sixty Wistar rats (80–120 g) were randomly assigned to six groups (n = 10). Groups A–C received standard chow, whereas Groups D–F received an HFHSD containing 30% vegetable oil and 25% sucrose for 28 days. Vitamin A (500 or 1000 IU/kg/day) was administered orally to Groups B and C, respectively, and co-administered with the HFHSD in Groups E and F. Behavioural and cognitive performance were assessed using the Open Field Test, Y-maze, and Novel Object Recognition test. Blood glucose, adiponectin, leptin, TNF-α, IL-6, IL-10, malondialdehyde (MDA), and total antioxidant capacity (TAC), and hippocampal and ileal histopathology were evaluated. HFHSD increased body weight gain, feed intake, TNF-α, IL-6, and MDA, while blood glucose was numerically higher but not significantly different from controls. Adiponectin, leptin, IL-10, and TAC were reduced, accompanied by impaired locomotor and exploratory activity, cognitive deficits, and intestinal and hippocampal histopathological alterations. Vitamin A attenuated metabolic, inflammatory, oxidative, behavioural, and histopathological alterations. The 500 IU/kg dose showed greater improvement in several behavioural and histological outcomes, whereas 1000 IU/kg produced stronger effects on antioxidant status and glycaemic regulation. These findings indicate dose-specific differences in the effects of vitamin A, although the optimal dose and underlying mechanisms remain to be established.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 583-595
Omega-3 Fatty Acids Attenuates Scopolamine-Induced Cognitive Dysfunction, Oxidative Stress and Hippocampal Structural Alterations in Wistar Rats
Scopolamine is a non-selective muscarinic antagonist widely used as a pharmacological model of cholinergic dysfunction and cognitive impairment. Omega-3 fatty acids may modulate neuronal, oxidative, and inflammatory processes; however, their effects following scopolamine exposure remain incompletely characterised. This study evaluated the effects of post-scopolamine omega-3 fatty acid supplementation on metabolic, behavioural, serum biochemical, and hippocampal CA1 structural parameters in adult male Wistar rats. Sixty, adult male Wistar rats (120–150 g) were randomly assigned to six groups (n = 10): control, omega-3 (250 and 500 mg/kg), scopolamine, and scopolamine + omega-3 (250 and 500 mg/kg). Scopolamine (0.7 mg/kg, intraperitoneally) was administered for 7 days, followed by oral omega-3 supplementation for 21 days. Metabolic, behavioural, serum biochemical, and hippocampal histomorphometric parameters were subsequently assessed. Scopolamine significantly altered body weight, feed intake, locomotor and exploratory activity, spontaneous alternation, and serum levels of MDA, TAC, inflammatory cytokines, and acetylcholine (p < 0.05). Post-scopolamine omega-3 supplementation attenuated several of these alterations. Histological and quantitative analyses revealed scopolamine-associated alterations in the hippocampal CA1 region, including reduced cellular and neuronal profiles, increased vacuolation, and changes in optical density and layer thickness. These alterations were attenuated following omega-3 supplementation, with the 500 mg/kg dose generally showing greater numerical improvement across several parameters. Omega-3 supplementation attenuated several behavioural, biochemical, and hippocampal structural alterations associated with scopolamine-induced cholinergic dysfunction, supporting further investigation of its potential ameliorative effects.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 583-595
Open AccessOmega-3 Fatty Acids Attenuates Scopolamine-Induced Cognitive Dysfunction, Oxidative Stress and Hippocampal Structural Alterations in Wistar Rats
Scopolamine is a non-selective muscarinic antagonist widely used as a pharmacological model of cholinergic dysfunction and cognitive impairment. Omega-3 fatty acids may modulate neuronal, oxidative, and inflammatory processes; however, their effects following scopolamine exposure remain incompletely characterised. This study evaluated the effects of post-scopolamine omega-3 fatty acid supplementation on metabolic, behavioural, serum biochemical, and hippocampal CA1 structural parameters in adult male Wistar rats. Sixty, adult male Wistar rats (120–150 g) were randomly assigned to six groups (n = 10): control, omega-3 (250 and 500 mg/kg), scopolamine, and scopolamine + omega-3 (250 and 500 mg/kg). Scopolamine (0.7 mg/kg, intraperitoneally) was administered for 7 days, followed by oral omega-3 supplementation for 21 days. Metabolic, behavioural, serum biochemical, and hippocampal histomorphometric parameters were subsequently assessed. Scopolamine significantly altered body weight, feed intake, locomotor and exploratory activity, spontaneous alternation, and serum levels of MDA, TAC, inflammatory cytokines, and acetylcholine (p < 0.05). Post-scopolamine omega-3 supplementation attenuated several of these alterations. Histological and quantitative analyses revealed scopolamine-associated alterations in the hippocampal CA1 region, including reduced cellular and neuronal profiles, increased vacuolation, and changes in optical density and layer thickness. These alterations were attenuated following omega-3 supplementation, with the 500 mg/kg dose generally showing greater numerical improvement across several parameters. Omega-3 supplementation attenuated several behavioural, biochemical, and hippocampal structural alterations associated with scopolamine-induced cholinergic dysfunction, supporting further investigation of its potential ameliorative effects.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 572-582
N-Acetylcysteine Attenuates Haloperidol-Induced Neurobehavioural, Oxidative, Inflammatory, and Cerebellar Histopathological Alterations in Wistar Rats
Haloperidol, a widely used first-generation antipsychotic, has been associated with neurotoxic effects within the central nervous system, including the cerebellum. However, the neuroprotective potential of N-acetylcysteine (NAC) against haloperidol-induced cerebellar toxicity remains insufficiently characterised. This study investigated the neurobehavioural, biochemical, and histomorphological effects of NAC in a rat model of haloperidol-induced cerebellar neurotoxicity. Sixty Wistar rats were randomly assigned to six groups (n = 10): control (distilled water), NAC-treated groups (500 and 1000 mg/kg), haloperidol (1 mg/kg), and haloperidol plus NAC (500 and 1000 mg/kg). Treatments were administered for 21 days, followed by behavioural assessment on day 22 using the open-field, catalepsy and elevated plus-maze tests. Animals were subsequently euthanised for biochemical and histological assessment of the cerebellar cortex. Haloperidol significantly reduced body weight, feed intake, and locomotor activity and increased catalepsy and anxiety-like behaviour. Haloperidol exposure was also associated with increased malondialdehyde, IL-6, IL-1β, TNF-α, and acetylcholine levels, together with reduced total antioxidant capacity and IL-10. Histological assessment revealed marked disruption of cerebellar architecture, including Purkinje cell loss and reduced neuronal density. Co-administration of NAC attenuated the haloperidol-associated neurobehavioural, biochemical, and histomorphological alterations, with the 1000 mg/kg dose generally producing greater attenuation than the 500 mg/kg dose. These findings indicate that NAC may confer neuroprotective effects against haloperidol-associated cerebellar toxicity, potentially through modulation of oxidative and inflammatory disturbances. Further mechanistic studies are warranted to establish the pathways underlying these effects.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 572-582
Open AccessN-Acetylcysteine Attenuates Haloperidol-Induced Neurobehavioural, Oxidative, Inflammatory, and Cerebellar Histopathological Alterations in Wistar Rats
Haloperidol, a widely used first-generation antipsychotic, has been associated with neurotoxic effects within the central nervous system, including the cerebellum. However, the neuroprotective potential of N-acetylcysteine (NAC) against haloperidol-induced cerebellar toxicity remains insufficiently characterised. This study investigated the neurobehavioural, biochemical, and histomorphological effects of NAC in a rat model of haloperidol-induced cerebellar neurotoxicity. Sixty Wistar rats were randomly assigned to six groups (n = 10): control (distilled water), NAC-treated groups (500 and 1000 mg/kg), haloperidol (1 mg/kg), and haloperidol plus NAC (500 and 1000 mg/kg). Treatments were administered for 21 days, followed by behavioural assessment on day 22 using the open-field, catalepsy and elevated plus-maze tests. Animals were subsequently euthanised for biochemical and histological assessment of the cerebellar cortex. Haloperidol significantly reduced body weight, feed intake, and locomotor activity and increased catalepsy and anxiety-like behaviour. Haloperidol exposure was also associated with increased malondialdehyde, IL-6, IL-1β, TNF-α, and acetylcholine levels, together with reduced total antioxidant capacity and IL-10. Histological assessment revealed marked disruption of cerebellar architecture, including Purkinje cell loss and reduced neuronal density. Co-administration of NAC attenuated the haloperidol-associated neurobehavioural, biochemical, and histomorphological alterations, with the 1000 mg/kg dose generally producing greater attenuation than the 500 mg/kg dose. These findings indicate that NAC may confer neuroprotective effects against haloperidol-associated cerebellar toxicity, potentially through modulation of oxidative and inflammatory disturbances. Further mechanistic studies are warranted to establish the pathways underlying these effects.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 557-571
Neuroprotective Effects of Sesame Seed Oil Against Chronic Stress-Induced Prefrontal Cortex Dysfunction in Wistar Rats
Stress disrupts physiological homeostasis and induces neurobehavioural, biochemical, and structural alterations in the brain, including impairment of prefrontal cortical function. Sesame seed oil, rich in lignans, tocopherols, phytosterols, and unsaturated fatty acids, possesses potential antioxidant and neuroprotective properties. This study investigated the effects of sesame seed oil on stress-induced neurobehavioural, biochemical, and histomorphological alterations in the prefrontal cortex of Wistar rats. Sixty adult Wistar rats weighing 150–200 g were randomly assigned to six groups (n = 10): Group A (normal control), Groups B and C (sesame seed oil, 1 and 2 mL/kg, respectively), Group D (stress control), and Groups E and F (stress + sesame seed oil, 1 and 2 mL/kg, respectively). Sesame seed oil was administered for 21 days, while unpredictable stress was applied during days 17–21. On day 22, behavioural assessments were conducted using the open field test, Y-maze, and elevated plus maze. Animals were subsequently euthanised, blood samples collected for biochemical analyses, and the prefrontal cortex processed for histological examination. Stress exposure significantly reduced body weight, feed intake, horizontal locomotion, rearing, Y-maze performance, and open-arm time, while increasing self-grooming and closed-arm time. Stress also significantly increased malondialdehyde, corticosterone, interleukin-6, and tumour necrosis factor-alpha levels, while reducing total antioxidant capacity and interleukin-10. Histomorphological examination revealed degeneration of pyramidal and glial cells in stressed rats. Sesame seed oil significantly attenuated these behavioural, biochemical, and histological alterations. These findings demonstrate the potential neuroprotective effects of sesame seed oil against stress-induced neural dysfunction and may warrant further investigation in stress-related disorders.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 557-571
Open AccessNeuroprotective Effects of Sesame Seed Oil Against Chronic Stress-Induced Prefrontal Cortex Dysfunction in Wistar Rats
Stress disrupts physiological homeostasis and induces neurobehavioural, biochemical, and structural alterations in the brain, including impairment of prefrontal cortical function. Sesame seed oil, rich in lignans, tocopherols, phytosterols, and unsaturated fatty acids, possesses potential antioxidant and neuroprotective properties. This study investigated the effects of sesame seed oil on stress-induced neurobehavioural, biochemical, and histomorphological alterations in the prefrontal cortex of Wistar rats. Sixty adult Wistar rats weighing 150–200 g were randomly assigned to six groups (n = 10): Group A (normal control), Groups B and C (sesame seed oil, 1 and 2 mL/kg, respectively), Group D (stress control), and Groups E and F (stress + sesame seed oil, 1 and 2 mL/kg, respectively). Sesame seed oil was administered for 21 days, while unpredictable stress was applied during days 17–21. On day 22, behavioural assessments were conducted using the open field test, Y-maze, and elevated plus maze. Animals were subsequently euthanised, blood samples collected for biochemical analyses, and the prefrontal cortex processed for histological examination. Stress exposure significantly reduced body weight, feed intake, horizontal locomotion, rearing, Y-maze performance, and open-arm time, while increasing self-grooming and closed-arm time. Stress also significantly increased malondialdehyde, corticosterone, interleukin-6, and tumour necrosis factor-alpha levels, while reducing total antioxidant capacity and interleukin-10. Histomorphological examination revealed degeneration of pyramidal and glial cells in stressed rats. Sesame seed oil significantly attenuated these behavioural, biochemical, and histological alterations. These findings demonstrate the potential neuroprotective effects of sesame seed oil against stress-induced neural dysfunction and may warrant further investigation in stress-related disorders.
- Open Access
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 542-557
Dose-Dependent Effects of a High-Sucrose Diet on Ovarian and Uterine Histomorphology and Hormonal Profile in Prepubertal Female Wistar Rats
High dietary sucrose intake has become a major public health concern because of its association with metabolic disorders and reproductive dysfunction. However, the dose-dependent effects of chronic sucrose consumption on female reproductive development during the prepubertal period remain poorly understood. This study investigated the effects of graded dietary sucrose concentrations on body weight, reproductive hormones, oxidative status, and the histomorphology of the ovaries and uterus in prepubertal female Wistar rats. Forty prepubertal female Wistar rats (3–4 weeks old; 50–60 g) were randomly assigned to four groups (n = 10/group). Group A received a standard diet and distilled water (control), while Groups B, C, and D received diets supplemented with 4%, 8%, and 16% sucrose, respectively, for 28 days. Body weight and feed intake were monitored throughout the experimental period. At study termination, blood samples were collected for hormonal and oxidative stress analyses, and ovarian and uterine tissues were harvested for histological evaluation using haematoxylin and eosin and Van Gieson staining. Data were analysed using one-way analysis of variance, with statistical significance set at p < 0.05. Sucrose supplementation produced dose-dependent increases in body weight and feed intake, with the greatest effects observed in the 8% and 16% sucrose groups. High-dose sucrose significantly increased progesterone concentrations while reducing luteinizing hormone, follicle-stimulating hormone, testosterone, and total antioxidant capacity compared with controls (p < 0.05). Histological examination demonstrated progressive ovarian follicular degeneration, granulosa cell disruption, stromal fibrosis, endometrial disorganization, glandular distortion, and increased collagen deposition, with the most pronounced alterations occurring in the 16% sucrose group. Chronic consumption of a high-sucrose diet during the prepubertal period induces dose-dependent endocrine imbalance, oxidative stress, and structural damage to the ovaries and uterus. These findings suggest that excessive dietary sucrose may adversely affect female reproductive development and could have long-term implications for reproductive health.
- 25 September 2026
- Published by Behavioural Neuroscience Research Group, LAUTECH
- Vol. 2 (5) , 542-557
Open AccessDose-Dependent Effects of a High-Sucrose Diet on Ovarian and Uterine Histomorphology and Hormonal Profile in Prepubertal Female Wistar Rats
High dietary sucrose intake has become a major public health concern because of its association with metabolic disorders and reproductive dysfunction. However, the dose-dependent effects of chronic sucrose consumption on female reproductive development during the prepubertal period remain poorly understood. This study investigated the effects of graded dietary sucrose concentrations on body weight, reproductive hormones, oxidative status, and the histomorphology of the ovaries and uterus in prepubertal female Wistar rats. Forty prepubertal female Wistar rats (3–4 weeks old; 50–60 g) were randomly assigned to four groups (n = 10/group). Group A received a standard diet and distilled water (control), while Groups B, C, and D received diets supplemented with 4%, 8%, and 16% sucrose, respectively, for 28 days. Body weight and feed intake were monitored throughout the experimental period. At study termination, blood samples were collected for hormonal and oxidative stress analyses, and ovarian and uterine tissues were harvested for histological evaluation using haematoxylin and eosin and Van Gieson staining. Data were analysed using one-way analysis of variance, with statistical significance set at p < 0.05. Sucrose supplementation produced dose-dependent increases in body weight and feed intake, with the greatest effects observed in the 8% and 16% sucrose groups. High-dose sucrose significantly increased progesterone concentrations while reducing luteinizing hormone, follicle-stimulating hormone, testosterone, and total antioxidant capacity compared with controls (p < 0.05). Histological examination demonstrated progressive ovarian follicular degeneration, granulosa cell disruption, stromal fibrosis, endometrial disorganization, glandular distortion, and increased collagen deposition, with the most pronounced alterations occurring in the 16% sucrose group. Chronic consumption of a high-sucrose diet during the prepubertal period induces dose-dependent endocrine imbalance, oxidative stress, and structural damage to the ovaries and uterus. These findings suggest that excessive dietary sucrose may adversely affect female reproductive development and could have long-term implications for reproductive health.